Abstract: Early diagnostics at the preclinical stage of Alzheimer's disease is of utmost importance for drug development in clinical trials and prognostic guidance. Since soluble Aβ oligomers are considered to play a crucial role in the disease pathogenesis, several methods aim to quantify Aβ oligomers in body fluids such as cerebrospinal fluid (CSF) and blood plasma. The highly specific and sensitive method surface-based fluorescence intensity distribution analysis (sFIDA) has successfully been established for oligomer quantitation in CSF samples. In our study, we explored the sFIDA method for quantitative measurements of synthetic Aβ particles in blood plasma. For this purpose, EDTA-, citrate-and heparin-treated blood plasma samples from five individual donors were spiked with Aβ coated silica nanoparticles (Aβ-SiNaPs) and were applied to the sFIDA assay. Based on the assay parameters linearity, coefficient of variation and limit of detection, we found that EDTA plasma yields the most suitable parameter values for quantitation of Aβ oligomers in sFIDA assay with a limit of detection of 16 fM.
Introduction
Alzheimer's disease (AD) is the most frequent form of dementia which affects more than 35 million people worldwide (Wimo et al., 2013) . Since age is considered to be the major risk factor for AD, case numbers are expected to dramatically increase in the next decades as a consequence of the aging society. The clinical onset of AD is preceded by pathophysiological changes years before outbreak of the disease (Blennow, 2004) . Early diagnostics at the preclinical stage of the disease is highly desired for drug development in clinical trials and prognostic guidance.
Major pathological hallmarks of AD are extracellular amyloid plaques consisting mainly of amyloid beta (Aβ) peptide as well as intracellular neurofibrillary tangles composed of tau protein (Selkoe, 1991) . More recent data indicate that oligomeric Aβ is the most toxic species and is therefore of interest both as drug target and candidate biomarker (Haass and Selkoe, 2007; Blennow et al., 2015) .
We developed a highly sensitive oligomer-specific diagnostic assay designated surface-based fluorescence intensity distribution analysis (sFIDA) (Birkmann et al., 2006 Funke et al., 2007 Funke et al., , 2010 Bannach et al., 2012; Wang-Dietrich et al., 2013; Kühbach et al., 2016) . In sFIDA, Aβ is captured to a functionalized glass surface by Aβ specific antibodies that recognize the N-terminus of the molecule. Subsequently, Aβ is decorated by two fluorescently labeled antibodies. Since the same or overlapping epitopes are recognized by both capture and detection antibodies, the assay is insensitive for monomeric Aβ which is also omnipresent in healthy subjects. Images from the surface are obtained using dual-color total internal reflection fluorescence microscopy (TIRFM). The number of colocalized pixels with signal intensities above background is referred to as sFIDA readout, which correlates with the number of Aβ oligomers in the sample. As a calibration standard in the sFIDA assay, 30 nm silica nanoparticles coated with Aβ 1−42 peptides (Aβ-SiNaPs) are used. Aβ-SiNaPs have been shown to be a suitable standard in Aβ oligomer quantitation due to their uniform size and defined number of accessible epitopes. Moreover, the particles are not prone to aggregation and are stable over several months .
sFIDA has been proven as a capable tool for the quantitation of Aβ oligomers from cerebrospinal fluid with a large sensitive range of detection. However, lumbar puncture, though generally considered to be safe, goes along with risks and is often experienced as uncomfortable for patients. Hence, the diagnosis from blood preparations after venipuncture is a worthwhile aim.
Blood can be processed either as serum or as plasma, which is the noncoagulated liquid component of blood after centrifugation. Coagulation is prevented by the addition of anticoagulants of which EDTA, citrate, and heparin are the most commonly used in clinical practice (Jambunathan and Galande, 2014) . EDTA and citrate prevent the formation of thrombin by chelating calcium required for the blood clotting cascade (Davie and Ratnoff, 1964) , whereas heparin functions by activating antithrombin (Olson and Chuang, 2002) .
The choice of anticoagulant for blood plasma preparation is an important factor in the preanalytical phase of assay development and can have a considerable effect on the identification of biomarkers as shown for a variety of assays concerning the detection of cytokines (Riches et al., 1992) , miRNA (Leidinger et al., 2015) , proteins (Banks et al., 2005; Hsieh et al., 2006) , enzymes (Gerlach et al., 2005) , amino acid analysis (Parvy et al., 1983; Hubbard et al., 1988; Chuang et al., 1998) and other analytes (Fendl et al., 2016; Ribeiro et al., 2016) .
The goal of the present study was to compare the effect of different anticoagulants on the sFIDA assay and identify the most suitable anticoagulant regarding assay standardization. Therefore, a dilution series of Aβ-SiNaPs was spiked in blood plasma supplemented with different anticoagulants (EDTA, citrate and heparin, respectively) and were subsequently applied to the sFIDA assay. Based on the assay parameters, linearity, coefficient of variance and limit of detection, the effect of the anticoagulants on the assay outcome was investigated.
Results
Aβ-SiNaPs were spiked in a log 10 dilution series to EDTA, citrate and heparin plasma, each of five individual healthy donors and subjected to sFIDA assay. As a preprocessing procedure all images underwent artifact detection.
For Aβ-SiNaPs spiked in EDTA plasma, citrate plasma, heparin plasma and PBS 81.4%, 87.9%, 88.0% and 89.2% of the total number of images passed quality control, respectively.
Inspection of the images for sFIDA analysis revealed differences for the different anticoagulants (Figures 1  and 2 ). For channel 0 (em. 635 nm/exc. 705 nm) the major peak in intensity distribution for EDTA was approximately at 2400, for citrate at 1700 and for heparin at 900 on a 14-bit grayscale, and for channel 1 (em. 488 nm/exc. 525 nm) at approximately 1300, 1300 and 1000, respectively (Figure 2) , as shown for blood plasma samples spiked in 1 pM Aβ-SiNaPs. This indicates that the overall intensity of images obtained from heparin treated blood plasma are considerably lower compared to EDTA and citrate, as can also be seen in representative images (Figure 1 , left hand column). Furthermore, the variation in intensity distribution between the images is higher for heparin compared to EDTA and citrate plasma ( Figure 1 , middle and right hand column).
For deeper analysis, sFIDA readout was calculated, which is the number of colocalized pixels above background. A correlation between Aβ-SiNaP concentration and sFIDA readout was observed from 100 pM down to the lowest concentration of 10 fM for all plasma samples (Figure 3) . In order to further characterize the effect of different anticoagulants on the sFIDA readout of Aβ-SiNaP spiked plasma samples, the linearity of the data was assessed as well as the coefficient of variation (CV) as a criterion for intra-assay precision and limit of detection (LOD) as a criterion for assay sensitivity were calculated.
Linearity
The sFIDA assay is known to have a wide detection range for Aβ oligomers. However, the linearity of the assay's readout is influenced by a variety of factors. To investigate the impact of anticoagulants in blood plasma samples on the linearity of the sFIDA readout, the Pearson's correlation coefficient, Mandel's fitting test, and the Lack-of-fit test were calculated (Table 1) .
Nearly ideal linear relationship in terms of Pearson's correlation of ρ = 0.94 was found for EDTA blood plasma and PBS diluents, whereas considerably lower values of ρ = 0.37 and ρ = 0.64 were obtained for dilutions in citrate and heparin blood plasma, respectively ( Table 2 ). As Pearson's correlation coefficient ρ has very limited significance as a criterion for linearity, Mandel's fitting test as well as Lack-of-fit test for the first and second order calibration curve was performed which are recommended and well established methods for testing linearity (Van Loco et al., 2002; Sanagi et al., 2010) . Likewise, Mandel's fitting test and Lack-of-fit test, respectively, indicate good linearity for EDTA plasma and PBS control, whereas for citrate and heparin a second order calibration curve is the function preferred (Table 1) .
Coefficient of variation
CV was calculated to assess intra-assay precision, which differs between the anticoagulants (Figure 4) . The lowest mean CV of 28% was obtained for EDTA plasma followed by 39% for citrate plasma and 67% for heparin plasma. For PBS a CV of 51% was obtained.
Limit of detection
LOD was calculated to investigate the effect of different anticoagulants on assay sensitivity as the mean for five donors. As each donor was measured in six replicates, the mean LOD calculation is based on 30 negative controls. Significant differences in mean LOD for Aβ-SiNaP dilution series in EDTA, citrate and heparin plasma 1 pM Aβ-SiNaP was spiked in blood plasma treated with different anticoagulants from a single donor and subsequently applied to sFIDA assay. A representative image as a composition of channel 0 (exc.: 635 nm, em.: 705 nm) and channel 1 (exc.: 488 nm, em.: 525 nm) is given for (A) EDTA, (B) citrate and (C) heparin-treated plasma, respectively (left hand), as well as cumulative intensity histograms for channel 0 (middle) and channel 1 (right hand). Cumulative histograms for single images are depicted in a light color whereas the mean cumulative histogram is depicted in a dark color. The variation in intensity distribution between the images is higher for heparin compared to EDTA and citrate.
as well as in PBS were observed ( Figure 5 ). The lowest mean LOD of 16 fM was obtained for Aβ-SiNaPs spiked in EDTA plasma followed by 19 fM (incl. outlier: 34 fM) for citrate, 27 fM for PBS and 34 fM (incl. outlier: 280 fM) for heparin. Additionally, the median LOD was calculated being more robust towards outliers as observed for citrate and heparin. In agreement with mean LOD, the lowest median LOD of 16 fM was obtained for Aβ-SiNaP spiked in EDTA plasma followed by 22 fM for citrate plasma, 23 fM for PBS and 31 fM for heparin plasma (data not shown).
Summary
Mean Pearson's correlation coefficient between spiked Aβ-SiNaPs and sFIDA readout, mean CV (%) and mean LOD for all three anticoagulants and PBS are summarized in Table 2 . Highest linearity, highest intra-assay precision and highest sensitivity of the sFIDA assay was obtained for Aβ-SiNaP-spiked EDTA plasma.
Discussion
The choice of anticoagulants for blood plasma preparation can have a significant impact on the detection of biomarkers. The aim of the present study was to compare the effect of different anticoagulants on the sFIDA readout and identify the most suitable anticoagulant regarding assay standardization. For this purpose, a dilution series of Aβ-SiNaPs was spiked in human blood plasma samples supplemented with different anticoagulants (EDTA, citrate and heparin, respectively) and was subsequently applied to the sFIDA assay. The assay outcome was evaluated by means of three parameters: the linearity of the sFIDA readout as a function of applied Aβ-SiNaP concentration, the coefficient of variation as well as the limit of detection.
The highest linearity for mean Pearson's correlation coefficient ρ of 0.94 was calculated for Aβ-SiNaPs spiked in EDTA plasma followed by heparin (ρ = 0.94) and citrate (ρ = 0.37) plasma. The lowest mean CV of 28% was obtained for EDTA followed by citrate (CV = 39%) and heparin plasma (CV = 67%). The lowest LOD of 16 fM was obtained for quantitation of Aβ-SiNaPs spiked in EDTA plasma followed by LOD of 19 fM and 34 fM for citrate and heparin plasma, respectively.
EDTA, citrate and heparin are the most common anticoagulants for blood plasma treatment in clinical practice. Whereas the anticoagulative effect of EDTA and citrate is attributed to the prevention of thrombin formation by chelating calcium required for the blood clotting cascade (Davie and Ratnoff, 1964) , heparin functions by activating antithrombin (Olson and Chuang, 2002) . Apart from this, heparin is known to bind to a variety of proteins including proteases, growth factors, chemokines, lipid binding proteins and adhesion proteins as summarized in Capila and For channel 0 (exc.: 635 nm, em.: 705 nm) the major peak in intensity distribution for EDTA is approximately at 2400, for citrate at 1700 and for heparin plasma at 900 on a 14-bit grayscale, and for channel 1 (exc.: 488 nm, em.: 525 nm) at approximately 1300, 1300 and 1000, respectively.
Linhardt (2002) and thus might modulate matrix effects significantly by affecting the biochemical constitution of blood plasma. Moreover, it has been shown in several studies that heparin binds directly to Aβ species (Watson et al., 1997; Madine et al., 2012; Nguyen and Rabenstein, 2016) possibly interfering with Aβ oligomer quantitation and accounting for the attenuating effects in sFIDA assay presented here.
Altogether, this is in line with studies on quantitation of total Aβ levels from blood plasma. Vanderstichele et al. (2000) reported that plasma collected in citrate and heparin tubes did not result in any measurable Aβ levels, whereas Aβ levels in EDTA plasma could be readily detected (Vanderstichele et al., 2000) . Lachno et al. (2009) determined total Aβ levels in serum, EDTA, citrate, heparin and fluoride plasma with highest Aβ levels in EDTA-treated plasma (Lachno et al., 2009 ).
The well-described binding of Aβ to various plasma proteins (Koudinov et al., 1994; Biere et al., 1996; Koudinov et al., 1998 ) might lead to a masking of epitopes and ultimately result in signal attenuation due to impaired capturing and probe detection. Previously, an interaction between prion protein aggregates and low density lipoproteins has been reported, making pretreatment with lipases and detergents necessary to counteract signal loss in sFIDA measurements (Safar et al., 2006; Bannach et al., 2012) . In the present study, however, the presence of EDTA plasma did not have any adverse effect on detection and quantitation of Aβ-SiNaP down to the low femtomolar range. Aβ-SiNaPs were serially diluted to 100 pM, 10 pM, 1 pM, 100 fM and 10 fM. As negative controls, non-spiked plasma samples were used (respective 0 m Aβ-SiNaP data points). Black rectangular symbols represent the sFIDA readout for donor 1, red circular symbols for donor 2, blue up-top triangular symbols for donor 3, magenta down-top triangular symbols for donor 4, green rhombical symbol for donor 5 and dark blue left-top triangular symbols for PBS control.
The achieved coefficient of variation of 28% is a severe issue for further improvement. Also, more validation parameters as suggested by Andreasson et al. (2015) (Andreasson et al., 2015) need to be addressed in future.
We conclude that EDTA is the most suitable anticoagulant for Aβ-SiNaP quantitation in blood plasma using the sFIDA assay. We therefore suggest that plasma samples for AD diagnosis in the sFIDA assay should be collected in EDTA tubes to ensure most accurate determination of Aβ oligomer levels in human blood plasma. Future investigations, however, will reveal whether humans do contain The assay outcome was evaluated by means of three parameters: the linearity of the sFIDA readout as a function of applied Aβ-SiNaP concentration (mean Pearson's correlation coefficient ρ), the mean coefficient of variation (CV) as well as the mean limit of detection (LOD).
detectable amounts of Aβ oligomers and whether they correlate with disease progression or prognosis. Thus, further work will focus on sFIDA measurements of clinical EDTA plasma samples from AD patients and controls in order to assess if Aβ oligomers can be exploited as a blood-based biomarker for AD.
Materials and methods

Plasma samples
A total of 15 blood plasma samples from five healthy donors were purchased from ZenBio, Inc. (BioCat GmbH, Heidelberg, Germany). Plasma samples were collected in BD Vacutainer tubes containing 12.15 mg K 2 EDTA per 7.0 ml sample, 158 USP units Heparin per 10.0 ml sample or 1 ml acid-citrate-dextrose solution B (4.8 g/l citric acid; 13.2 g/l Na 3 Citrate; 14.7 g/l dextrose) per 6 ml sample, respectively. To avoid repeated freeze/thaw cycles, plasma samples were directly aliquoted and stored at -80°C until usage. Prior to aliquoting, plasma samples were centrifuged for 10 min at 20 000 g and the supernatant was preserved.
Silica nanoparticles coated with Aβ 1-42 (Aβ-SiNaPs)
Aβ-SiNaPs were prepared as described previously . Briefly, bare silica nanoparticles (SiNaPs) were synthesized via Stöber process and silanized with APTES to cover the surface with primary amino groups. Subsequent reaction with succinic anhydride resulted in carboxylated SiNaPs, which were activated by EDC/NHS for covalent coupling of Aβ 1−42 . The same batch of Aβ-SiNaPs was used for all spiking experiments to ensure equal size (diameter of approx. 30 nm) of the particles and Aβ distribution on the surface. The mean limit of detection (LOD) for Aβ-SiNaPs spiked in blood plasma was obtained for six replicate measurements of each dilution series in samples from five different donors. The LOD was calculated from the sFIDA readout from the respective negative control plus three times the standard deviation. The lowest mean LOD of 16 fM was obtained for Aβ-SiNaPs spiked in EDTA plasma followed by 19 fM (incl. outlier: 34 fM) for citrate, 27 fM for PBS and 34 fM (incl. outlier: 280 fM) for heparin.
1 nM Aβ-SiNaP stock solution was serially diluted to 100 pM, 10 pM, 1 pM, 100 fM and 10 fM in plasma samples and PBS.
sFIDA protocol
For sFIDA assay a 384-well multititer plate (SensoPlate plus, Greiner Bio-One International, Frickenhausen, Germany) was used. All of the protocol steps were carried out under the clean bench to avoid dust and microbial contamination. Prior to functionalization of the glass surface, wells were cleaned with sodium hydroxide and hydrochloric acid. 5 m NaOH (Carl Roth, Karlsruhe, Germany) was applied for 15 min to the wells (95 μl/well) followed by three washing steps with the same volume of water. Immediately, 1 m HCl (32%, AnalaR NORMAPUR, VWR Chemicals, France) was incubated for 15 min in the wells (95 μl/well) followed by three washing steps with water and two washing steps with 70% ethanol (AnalaR NORMAPUR, VWR Chemicals, France). Shortly after wells dried at room temperature (RT), 45 μl of a DMSO (Sigma-Aldrich, Steinheim, Germany) ethanolamine mixture (Sigma-Aldrich, Steinheim, Germany) (v/v 2:3) was added to the wells and incubated overnight at RT. Afterwards, the wells were washed twice with DMSO and twice with 95 μl/well 70% ethanol and left to dry. In the meantime, NHS-PEG-COOH (MW 5000, Laysan Bio, USA) was solved at 70°C in DMSO and cooled down to RT. 15 μl of 2 mm PEG solution were applied per well for 1 h followed by three washing steps with water. Activation of the PEG carboxyl groups was then performed by applying 30 μl/well of 100 mm EDC (Fluka, Buchs, Switzerland) and 100 mm NHS (Aldrich, Milwaukee, USA) mixture (v/v 1:1) in 0.1 m MES (Carl ROTH, Karlsruhe, Germany) buffer (pH 3.5) for 30 min. After washing the wells three times quickly with MES buffer, 15 μl/well capture antibody was added immediately for 1 h to the wells. As capture antibody, monoclonal anti-β-amyloid antibody NAB228 (Sigma-Aldrich, Steinheim, Germany) was diluted in PBS (Dulbecco's phosphate buffered saline 10×, Sigma-Aldrich, Steinheim, Germany) to a final concentration of 10 ng/μl and centrifuged at 15 000 g for 10 min to remove the unsoluble components. Hereafter, the wells were washed twice with PBS-T (PBS + 0.05% Tween-20, Sigma-Aldrich, Steinheim, Germany) and twice with PBS. Next the surface was blocked with 50 μl/well Smart Block solution (Candor Bioscience, Wangen, Germany) followed by two washing steps with PBS-T and two steps with PBS. 15 μl/well sample was then applied to the surface and incubated overnight. Unbound sample components were removed by two washing steps with PBS-T and two washing steps with PBS. Finally, fluorescently labeled detection antibodies 6E10 Alexa Fluor 488 (Covance, Princeton, USA) and NAB228 Alexa Fluor 647 (Santa Cruz, Dallas, USA) were combined to the final concentration of 1.25 ng/μl each, centrifuged at 100 000 g for 1 h and applied to the wells (15 μl/well). After final washing twice with PBS-T and twice with PBS, wells were filled with 95 μl PBS.
Data acquisition
Acquisition of 14-bit grayscale images was performed using total internal reflection microscopy (AM TIRF MC, Leica Microsystems, Wetzlar, Germany). A total of 50 images per well (25 positions per channel) containing 1000 × 1000 pixels each were obtained for channel 0 (excitation at 635 nm, emission filter 705/72 nm) and channel 1 (excitation at 488 nm, emission filter 525/36 nm). The image size represents an area of 116 μm × 116 μm, thus in total 3.15% of the well surface (approximately 10 nm 2 ) were scanned. Laser intensity of 100%, exposure time between 1 s and 1.5 s and gain between 900 and 1000 were applied for image acquisition.
Artifact detection
Prior to data analysis, artificial images were removed from raw data pool applying two algorithms based on histogram analysis and cluster detection, respectively.
First, images were subjected to histogram artifact detection. This method is based on calculating the histogram for each image and counting the peaks by determination of local maxima in the histogram. Images with multimodal histograms (histograms containing more than one histogram maximum) were considered artificial and were excluded from further analysis. The image histogram was smoothed using 800 values for binning to eliminate background noise and thus avoid detection of local maxima. Via numerical differentiation the derivative of the smoothed histogram was calculated, which was then smoothed in the same way as the original histogram. After smoothing procedures, some rest noise can still cause local maxima especially at points where function overlaps the x-axis. In order to determine the parameters for exclusion of images based on their histogram, a threshold was defined that includes two components: α and β. α is the number of pixels that form a maximum, β is a number of pixels that form a minimum. Only if α and β of adjacent maximum and minimum are high enough to meet α and β limits, a maximum was treated as a maximum. α limit of 400 and β limit of 300 were chosen as parameters for maxima determination.
Second, images with unimodal histograms (histograms with a single maximum) can still contain artifacts in form of large and/or bright spots. To detect these spots, a cluster detection algorithm was applied to the images. This method is based on finding of agglomerations of pixels with intensities above a certain threshold. Depending on such parameters as cluster size, mean pixel intensity and standard deviation within a cluster, bright spots are identified as artifacts. Obtained grayscale images were transformed into binary images. The grayscale values with intensities ≤ mean grayscale value plus one standard deviation were set to 0, all others to 1. Using a rectangular structuring element with the size of 15 pixels × 15 pixels the images were eroded to identify large clusters and eliminate the small ones which represent Aβ-SiNaPs. To compensate pixel loss caused by erosion, dilation was applied to eroded images using the same structuring element.
An image was considered artificial and was excluded from further analysis, if at least one cluster fulfilled one of the following criteria: mean pixel intensity of more than 3000, a standard deviation of pixel intensity of more then 2800 or skewness of less than 0.
Data analysis
sFIDA readout: For data analysis of non-artificial images only a region of interest (ROI) consisting of the central 700 pixels × 700 pixels (corresponding to 490 000 pixels per image in total) was chosen in order to minimize the effects of inhomogeneous illumination of edge regions in TIRF microscopy images.
To reduce background noise, cutoffs were determined individually for each plasma sample based on the non-spiked control. This approach accounts for donor-specific background or signal by native Aβ oligomers which may influence the readout. For Aβ-SiNaPs diluted in PBS, the cutoff was determined from PBS control. The cutoff values for each channel were determined as the intensity, which was exceeded by 1% of total pixels. Number of colocalized pixels from both channels above the respective cutoff is referred to as sFIDA readout below.
The effects of different anticoagulants in plasma on sFIDA readouts were studied according to the criteria described below.
Linearity of the sFIDA readout
Pearson's correlation coefficient Pearson's correlation coefficient (ρ) was calculated with MATLAB software as a criterion for linearity of the correlation between applied concentrations of Aβ-SiNaPs and obtained sFIDA readouts according to the formula:
where x is concentration of Aβ-SiNaPs, y is the sFIDA readout and N is the number of x,y pairs. Prior to mean value calculation, Olkin & Pratt correction was performed on Pearson's correlation coefficients (Olkin and Pratt, 1958; Eid et al., 2013) . Briefly, ρ was transformed to G i according to the formula:
where n is the number of samples in study i. Next, the weighted mean of G i values was calculated for studies from i = 1,…,k according to the formula:
Thus, G is an estimator for mean correlation.
Test for linearity according to Mandel (Mandel's test)
The linearity of the sFIDA readout was further investigated using Mandel's fitting test (Mandel, 1964) . This method provides evidence on linearity under consideration of the residual standard deviation for the first (linear) and second order (quadratic) calibration function. The H 0 hypothesis assumes no significant difference between the residual variances of the linear and quadratic calibration function. The Mandel's test was performed as follows (Funk et al., 2005; Bruggemann et al., 2006) : the first and second order calibration functions are calculated including the residual standard deviations For PW < F crit,99% H 0 is accepted. The second order calibration function will not provide a significantly better fit; the calibration function of choice is linear.
For PW > F crit,99% H 0 is retained, which indicates non-linearity (Bruggemann et al., 2006) .
Lack-of-fit test
The Lack-of-fit test (Massart, 1997) is performed by comparing the ratio of the error due to lack of fit of the respective calibration function and the error due to pure error obtained from replicative measurements with F crit,99% at (k-2) and (n-k) degrees of freedom at the significance level α = 0.01. The H 0 hypothesis assumes no lack of fit.
The Lack-of-fit test is calculated as follows: first, the sum of squares due to pure error and due to lack of fit are calculated, respectively: i y estimation obtained from the respective regression analysis at i. Next, the mean squares are calculated by dividing the sum of squares by the corresponding degrees of freedom (Massart, 1997 
MS MS =
For LOF < F crit,99% H 0 is accepted. There is no lack of fit. For LOF > F crit,99% H 0 is rejected. Saturated images for which sFIDA readout reached the maximum value of 490 000 (100 pM and 10 pM Aβ-SiNaPs in EDTA plasma as well as 100 pM Aβ-SiNaPs in PBS) were excluded from this analysis.
Coefficient of variation
CV was calculated as a criterion for intra-assay precision using Excel software. CV was calculated for each three replicate measurements for each standard concentration and negative control. The mean for each donor and each diluent was plotted using MATLAB software. Saturated images for 100 pM and 10 pM Aβ-SiNaPs in EDTA plasma as well as 100 pM Aβ-SiNaPs in PBS were excluded from this analysis.
Limit of detection
LOD was used as a criterion for sensitivity of the sFIDA assay. LOD was calculated as the mean from sFIDA readout for 6-fold replicate measurements of negative control (neg. control) from five individual donors (30 negative controls in total) and respective standard deviation (σ) according to the formula: (neg. control) LOD sFIDA readout 3 σ = +
Linear calibration curves for the correlation between concentrations of Aβ-SiNaPs and sFIDA readout for LOD determination were calculated with MATLAB software. Only values within the linear range of the obtained data were included for calculating the linear calibration curves (concentrations of 10 fM, 100 fM and 1 pM for all donors and anticoagulants). Using these calibration curves, the sFIDA readouts were correlated to their respective concentration.
